RBP-ReguNet Deconstructing and Rewiring RNA-RBP regulatory networks
- Coordinator
- Universidad De Santiago De Compostela, Spain
- Runs
- 1 March 2023 to 28 February 2027
- Status
- Running
- EU funding
- €2.6m
- Total cost
- —
- Partners
- 15 organisations in 6 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101073094
What the project is doing
In the project's own words, from its summary on CORDIS.
RNA-binding proteins (RBPs) are critical regulators of gene expression programs. They regulate all aspects of RNA life, including transcription, splicing, modification, localization, stability, translation and decay, and consequently, perturbations in these RBP-RNA networks underlie the origin of many diseases. Recent proteomics-based studies have vastly expanded the repertoire of RBPs to the thousands, uncovering unconventional RBPs such as metabolic enzymes ‘moonlighting’ in RNA-binding activity or RNAs “riboregulating” protein function.
This represents a much broader layer of biological control that was previously envisaged, which adds an entirely new dimension to RBP-dependent regulation of cellular homeostasis. RBP-ReguNet has been conceived to leverage these new discoveries to identify druggable targets for a range of untreatable diseases, including cancer, neurological disorders, liver diseases and infectious disease. Our ambition in RBP-ReguNet is to create a high-level training program based on basic research but with a strong impact on clinical translation.
RBP-ReguNet will provide advanced multidisciplinary scientific training that spans from computational, structural, molecular and cellular biology to medicinal chemistry and pharmacological screening, to the next generation of European researchers in an intersectoral environment to pursue ambitious and high gain research on the development of new therapies based on RBP biology. They will be trained in a range of core and state-of-the-art discipline-specific research skills, complementary transferable skills, and entrepreneurial skills by secondments to non-academic partners, with a common focus to discover actionable targets.
This network of excellence will push the boundaries of knowledge in the protein-RNA interactions universe, and at the same time provide the next generation of students with the skills to become future leaders in the field.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad De Santiago De Compostela | Santiago De Compostela | Spain | Coordinator |
| European Molecular Biology Laboratory | Heidelberg | Germany | Participant |
| Fundacio Centre De Regulacio Genomica | Barcelona | Spain | Participant |
| Fundacion Kertor | Santiago De Compostela | Spain | Associatedpartner |
| Universidad Pompeu Fabra | Barcelona | Spain | Associatedpartner |
| Institut Curie | Paris | France | Participant |
| Ribonexus | Villejuif | France | Associatedpartner |
| Universite Paris-Saclay | Gif-Sur-Yvette | France | Associatedpartner |
| Consiglio Nazionale Delle Ricerche | Roma | Italy | Associatedpartner |
| Immagina Biotechnology SRL | Trento | Italy | Participant |
| Universita Degli Studi Di Milano | Milano | Italy | Participant |
| Universita Degli Studi Di Trento | Trento | Italy | Participant |
| Stichting Sanquin Bloedvoorziening | Amsterdam | Netherlands | Participant |
| Universiteit Van Amsterdam | Amsterdam | Netherlands | Associatedpartner |
| University of Glasgow | Glasgow | United Kingdom | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI